# Characterizing motor–cognitive associations in Parkinson’s disease using digital assessments

**Authors:** Avigail Lithwick Algon, William Saban

PMC · DOI: 10.3389/fnagi.2026.1787521 · Frontiers in Aging Neuroscience · 2026-02-23

## TL;DR

This study shows that remote assessments can effectively measure cognitive and motor connections in Parkinson’s disease, similar to in-person evaluations.

## Contribution

The study establishes that remote cognitive assessments capture motor–cognitive associations comparable to in-person evaluations in Parkinson’s disease.

## Key findings

- Remote MoCA assessments correlate with motor measures similarly to in-person assessments.
- Each increase in disease stage correlates with a significant decrease in MoCA scores in both in-person and online settings.

## Abstract

Traditional motor and cognitive assessments for people with Parkinson’s disease (PD) have long faced challenges related to accessibility, scalability, and geographical diversity when administered in-person. Remote cognitive testing offers the promise of improved accessibility, reduced participant burden, and greater scalability, particularly for individuals with mobility limitations or limited access to specialized care. While remote cognitive assessments are increasingly used in PD research and clinical settings, it remains unclear whether these measures provide an informative index of PD severity. These gaps limit the interpretability and broader adoption of remote cognitive measures as accessible and scalable indicators of PD severity. To establish a benchmark, we first analyzed a large in-person dataset (PPMI; n = 1,417). We found significant, negative, and small correlations between a cognitive measure (MoCA) scores and two motor measures (MDS-UPDRS III, ρ = −0.17; and H&Y scores, ρ = −0.12). Second, we administered remote assessments to 152 individuals with PD across 60+ geographical locations, including a videoconference-based MoCA (MoCA-VC) and online versions of the MDS-UPDRS III and H&Y. Consistent with in-person findings, we found significant, negative, and small correlations between the MoCA-VC scores and the two motor measures (MDS-UPDRS III, ρ = −0.32; and H&Y scores, ρ = −0.16). Additionally, we examined the decrease in the MoCA score as a function of disease stage. A multivariable regression model demonstrated that each one disease stage increase in H&Y was associated with a 0.65-point decrease in MoCA (in-person settings) and a 1.16-point decrease in MoCA-VC (online settings). Together, these findings demonstrate that a remote, home-based cognitive assessment captures motor–cognitive associations comparable to those observed in large in-person settings, supporting its potential utility as an accessible and scalable cognitive index of PD severity.

## Linked entities

- **Diseases:** Parkinson’s disease (MONDO:0005180)

## Full-text entities

- **Genes:** DOCK3 (dedicator of cytokinesis 3) [NCBI Gene 1795] {aka MOCA, NEDIDHA, PBP}
- **Diseases:** PD (MESH:D010300), MCI (MESH:D060825), falls (MESH:C537863), Instability and Gait Disorder (MESH:D020233), fatigue (MESH:D005221), mobility limitations (MESH:D051346), PIGD (MESH:D054972), Bradykinesia (MESH:D018476), Tremor (MESH:D014202), H&amp;Y (MESH:C536297), Parkinson (MESH:D010302), rigidity (MESH:D009127), Motor impairments (MESH:D000068079), cognitive deficits (MESH:D003072), Movement Disorder (MESH:D009069)
- **Chemicals:** dopaminergic medication (-), dopaminergic (MESH:D004298)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12968210/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12968210/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12968210/full.md

---
Source: https://tomesphere.com/paper/PMC12968210